For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

Knowing what to ask your doctor about your CLL treatment can help you feel more comfortable with your diagnosis and know what to expect for the future. There are many treatment options ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

Different chronic lymphocytic leukemia (CLL) treatments and their side effects can be dehydrating. You can take steps to reduce the risk of dehydration. If you’re not able to keep up with your ...

Co-Located Cell Types Help Drive Aggressive Brain Tumors Feb. 7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth ...

Patients with CLL and a CSHA CFS score greater than 3 had significantly higher rates of treatment interruption due to adverse effects. The CSHA Clinical Frailty Scale (CFS) is a valuable tool for ...

Which of the statements below about the genetics of chronic lymphocytic leukemia (CLL) are correct? Select one of the options for each question, then submit your answers to see how well you scored and ...

But [in] a lot of situations, I think it would be safe. Do you have any trial or clinical experience using pirtobrutinib? When would you select pirtobrutinib for your patients with relapsed/refractory ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax to Present at the 37th Annual Roth Conference 11.03.2025 / 14:06 CET/CEST The issuer is solely responsible for the content of this ...